Sep 25
Midcap holds up to 5 mid caps above $2B, drawn from the most volatile third of the band by the model's volatility score.
Equal capital goes into every recommendation. Recommendations are published a few hours before the open and placed as market orders, so buys and sells fill at the opening price. Positions are held for 6 to 8 days. Every position carries a 25% stop-loss: if the price touches it during the day, the position is sold there, at 75% of its entry price. Reported returns are measured from those opening prices and include every stop-loss exit.
Goldman Sachs reinstated coverage of Iovance with a Buy rating and a $15 price target on September 24, 2026. The firm cited improving operational efficiencies and gross margins for the company's lead product, Amtagvi, as key drivers for future growth.
GurufocusInvestors are reacting to a proposed 2027 Medicare lab rate update that could reduce reimbursement by up to 15% for several key tests. This potential regulatory change threatens future revenue and margins, contributing to recent stock price volatility and downward pressure.
TipRanksB. Riley Securities increased its price target for Strive from $26 to $33 while maintaining a Buy rating. This analyst action reflects growing institutional confidence in the company's Bitcoin treasury model and its positioning as a beneficiary of potential regulatory shifts.
MarketBeatStrive disclosed the purchase of 1,355 Bitcoin for approximately $107.7 million, bringing its total treasury holdings to 26,355 BTC. This ongoing accumulation strategy is a primary driver of the stock's performance and market narrative as a high-beta Bitcoin proxy.
Strive.comREX Shares and Tuttle Capital launched the ASSX ETF, which provides 2x leveraged exposure to Strive's daily performance. The introduction of this financial product has increased trading interest and volatility in ASST shares by deepening market exposure.
Business WireIovance reported the grant of 179,750 stock options to new non-executive employees on September 18, 2026. While routine, such filings are monitored for dilution impact and corporate growth signals.
BioSpace